Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-02-26 @ 12:36 AM
Study NCT ID:
NCT01762202
Status:
COMPLETED
Last Update Posted:
2020-10-14
First Post:
2013-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-04
First Submit QC Date:
None
Study First Post Date:
2013-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-12
Last Update Post Date:
2020-10-14
Last Update Post Date Type:
ACTUAL